文献速递瓣膜外科

透析依赖患者心脏瓣膜选择:机械瓣与生物瓣的荟萃分析

Mechanical or biological heart valve for dialysis-dependent patients? A meta-analysis.
PubMed 文献 · J Thorac Cardiovasc Surg · 2020-07-05

该系统综述与荟萃分析纳入24项回顾性研究共10164例透析依赖患者,比较机械瓣与生物瓣在主动脉瓣或二尖瓣置换中的效果。主动脉瓣置换中机械瓣长期生存更优(HR 0.64),二尖瓣置换中两者生存相似(HR 0.90);机械瓣结构瓣衰败率更低但INR>2.5时出血风险显著增加。

要点

  • 主动脉瓣置换透析患者机械瓣长期生存优于生物瓣(HR 0.64,95%CI 0.47-0.86)。
  • 二尖瓣置换透析患者机械瓣与生物瓣生存无显著差异(HR 0.90,95%CI 0.73-1.12)。
  • INR>2.5时机械瓣出血风险显著高于生物瓣(IRR 10.58,95%CI 2.02-55.41)。

核心结论

  • 无额外血栓栓塞风险的主动脉瓣置换透析患者,机械瓣因长期生存更优、耐久性更好且出血风险不劣于生物瓣,是合理选择。
  • 二尖瓣置换透析患者,生物瓣因生存率相似且出血风险更低,可能是合适选择。

研究设计与样本

  • 系统综述与荟萃分析,纳入24项回顾性研究(无随机对照试验),共10164例透析依赖患者(机械瓣6934例,生物瓣3230例)。
  • 采用随机效应模型进行荟萃分析,并按瓣膜位置和术后INR进行亚组分析,使用荟萃回归检验研究水平协变量效应。

主要发现

  • 主动脉瓣置换机械瓣长期生存优于生物瓣(HR 0.64,95%CI 0.47-0.86)。
  • 二尖瓣置换机械瓣与生物瓣生存差异无统计学意义(HR 0.90,95%CI 0.73-1.12)。
  • INR>2.5时机械瓣出血风险显著高于生物瓣(IRR 10.58,95%CI 2.02-55.41);INR<2.5时出血事件相当(IRR 1.73,95%CI 0.78-3.82)。
  • 机械瓣结构瓣衰败率显著低于生物瓣(RR 0.24,95%CI 0.14-0.44)。

关键数值与推荐

  • 主动脉瓣置换透析患者机械瓣长期生存HR 0.64(95%CI 0.47-0.86)。
  • 二尖瓣置换透析患者机械瓣与生物瓣生存HR 0.90(95%CI 0.73-1.12)。
  • INR>2.5时机械瓣vs生物瓣出血IRR 10.58(95%CI 2.02-55.41);INR<2.5时IRR 1.73(95%CI 0.78-3.82)。
  • 机械瓣vs生物瓣结构瓣衰败RR 0.24(95%CI 0.14-0.44)。

临床怎么用

  • 透析依赖患者行主动脉瓣置换且无额外血栓栓塞风险时,可优先考虑机械瓣以改善长期生存和耐久性。
  • 透析依赖患者行二尖瓣置换时,生物瓣因生存相似且出血风险更低可作为合适选择。
  • 术后INR管理需平衡出血风险,INR>2.5时机械瓣出血风险显著增加。

局限性

  • 仅纳入回顾性研究,无随机对照试验,存在选择偏倚可能。
  • 年龄对长期生存差异影响小,但需进一步按年龄分层研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The optimal selection of prosthetic heart valve for dialysis-dependent patients remains controversial. We investigated the comparative effectiveness and safety of mechanical prosthesis (MP) and bioprosthesis (BP) for these patients. METHODS: After the systematic review, we included studies that involved patients on dialysis undergoing aortic valve replacement or mitral valve replacement (MVR) and reported comparative outcomes of MP and BP. Meta-analysis was performed using random-effects model. We conducted a subgroup analysis based on the valve position and postoperative international normalized ratio (INR), which was extracted from either tables or methods of each study. A meta-regression was used to examine the effects of study-level covariates. RESULTS: We included 24 retrospective studies without randomized-controlled trials, involving 10,164 participants (MP = 6934, BP = 3230). Patients undergoing aortic valve replacement with MP exhibited a better long-term survival effectiveness (hazard ratio, 0.64; 95% confidence interval [CI], 0.47-0.86). Conversely, studies including MVR demonstrated little difference in survival (hazard ratio, 0.90; 95% CI, 0.73-1.12). A meta-regression revealed that age had little effect on long-term survival difference between MP and BP (β = -0.0135, P = .433). MP had a significantly greater bleeding risk than did BP when INR was above 2.5 (incidence rate ratio, 10.58; 95% CI, 2.02-55.41). However, when INR was below 2.5, bleeding events were comparable (incidence rate ratio, 1.73; 95% CI, 0.78-3.82). The structural valve deterioration rate was significantly lower in MP (risk ratio, 0.24; 95% CI, 0.14-0.44). CONCLUSIONS: MP is a reasonable choice for dialysis-dependent patients without additional thromboembolic risk requiring aortic valve replacement, for its better long-term survival, durability, and noninferior bleeding risk compared with BP. Conversely, BP might be an appropriate selection for patients with MVR, given its similar survival rate and lower bleeding risk. Although our meta-regression demonstrates little influence of age on long-term survival difference between MP and BP, further studies stratifying patients based on age cut-off are mandatory.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Chi KY, Chiang MH, Kang YN, et al. Mechanical or biological heart valve for dialysis-dependent patients? A meta-analysis. J Thorac Cardiovasc Surg. 2020. PMID: 32778466. doi:10.1016/j.jtcvs.2020.05.101

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。